Olmesartan Medoxomil 20mg + Metoprolol Succinate 47.5mg ER Tablets$51.00
1–9 boxes
$51.00 each
10–24 boxes
8% off
25+ boxes
10% off
Olmesartan Medoxomil 20mg + Metoprolol Succinate 47.5mg ER Tablets
SKU GME881Product Introduction
Olmesartan Medoxomil 20mg + Metoprolol Succinate 47.5mg combines an angiotensin-receptor blocker with a beta blocker for high blood pressure. It reduces vascular resistance and heart-rate-related cardiac workload through complementary mechanisms.
How to use
Take with or after food at a consistent time. Swallow prolonged-release tablets whole without crushing or chewing. Do not stop abruptly because sudden beta-blocker withdrawal can worsen angina or cause rebound cardiovascular symptoms.
How it works
Olmesartan blocks angiotensin II-mediated vessel tightening. Metoprolol preferentially blocks cardiac beta-1 receptors, slowing the heart and reducing its response to adrenergic stimulation.
Side effects
Dizziness, fatigue, slow pulse, low blood pressure and increased potassium can occur. Fainting, severe breathlessness or a very slow heartbeat needs prompt assessment.
Important information
Pregnancy is excluded because of olmesartan. Heart block, marked bradycardia and unstable decompensated heart failure affect suitability. Asthma and diabetes are important because beta blockade can affect breathing and mask some low-glucose warning symptoms.
Uses
- Hypertension requiring combined olmesartan and metoprolol treatment.
Benefits
Combines blood-vessel relaxation with heart-rate control when both effects are needed in the intended antihypertensive regimen.
Why should Olmesartan Medoxomil 20mg + Metoprolol Succinate 47.5mg not be stopped suddenly?
Abrupt withdrawal of metoprolol can cause rebound sympathetic activity and worsen angina or other cardiac symptoms.
Does it lower the pulse as well as blood pressure?
Yes. The metoprolol component can slow heart rate, so pulse is part of monitoring.
Can it hide a low-glucose episode?
Beta blockade can reduce warning signs such as palpitations; sweating or other symptoms may still occur.
Why do some labels show 47.5mg and others 50mg?
Some products state the succinate salt mass, while others use a metoprolol tartrate-equivalent convention. Exact composition matters when comparing them.
Can it be used as an extra dose for a single high reading?
An extra tablet also increases beta-blocker exposure and can cause excessive slowing of the heart.
Beta-1 blocker: a medicine that reduces adrenergic stimulation of the heart. Bradycardia: an unusually slow heart rate. ARB: an angiotensin-receptor blocker. Salt equivalent: a way of expressing a drug amount using a reference salt; AR: Olmesartan Medoxomil 20mg + Metoprolol Succinate 47.5mg أقراص ممتدة التحرر; FR: Olmesartan Medoxomil 20mg + Metoprolol Succinate 47.5mg comprimés à libération prolongée; PT: Olmesartan Medoxomil 20mg + Metoprolol Succinate 47.5mg comprimidos de libertação prolongada; ES: Olmesartan Medoxomil 20mg + Metoprolol Succinate 47.5mg comprimidos de liberación prolongada; RU: Olmesartan Medoxomil 20mg + Metoprolol Succinate 47.5mg таблетки пролонгированного высвобождения; ID: Olmesartan Medoxomil 20mg + Metoprolol Succinate 47.5mg tablet lepas lambat; VI: Olmesartan Medoxomil 20mg + Metoprolol Succinate 47.5mg viên nén giải phóng kéo dài; MS: Olmesartan Medoxomil 20mg + Metoprolol Succinate 47.5mg tablet pelepasan berpanjangan; TL: Olmesartan Medoxomil 20mg + Metoprolol Succinate 47.5mg tabletang may pinalawig na paglabas; ZH-SG: Olmesartan Medoxomil 20mg + Metoprolol Succinate 47.5mg 缓释片